Journal article
Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4
K Fisher, TE Schlub, Z Boyer, TA Rasmussen, A Rhodes, R Hoh, FM Hecht, SG Deeks, SR Lewin, S Palmer
Frontiers in Immunology | Published : 2023
Abstract
Introduction: HIV-1 persists in resting CD4+ T-cells despite antiretroviral therapy (ART). Determining the cell surface markers that enrich for genetically-intact HIV-1 genomes is vital in developing targeted curative strategies. Previous studies have found that HIV-1 proviral DNA is enriched in CD4+ T-cells expressing the immune checkpoint markers programmed cell death protein-1 (PD-1) or cytotoxic T-lymphocyte associated protein-4 (CTLA-4). There has also been some success in blocking these markers in an effort to reverse HIV-1 latency. However, it remains unclear whether cells expressing PD-1 and/or CTLA-4 are enriched for genetically-intact, and potentially replication-competent, HIV-1 g..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
This work was supported by the Delaney AIDS Research Enterprise (DARE) to Find a Cure (1UM1AI126611-01 and 1UM 1AI164560-01) and the Australian National Health and Medical Research Council (APP1149990).